Hypotension Prediction 2 Study in Cardiac Surgery and Postoperative ICU Admission (HYPE-2)
Intraoperative Hypotension, Postoperative Hypotension, Hypotension
About this trial
This is an interventional prevention trial for Intraoperative Hypotension focused on measuring Intensive Care Unit, Cardiac surgery, Coronary Artery Bypass Grafting
Eligibility Criteria
Inclusion Criteria: Aged 18 years or older at inclusion Planned for elective on-pump CABG surgery or CABG with additional single heart valve surgery (e.g. valve repair or replacement) Planned to receive standard monitoring for cardiac surgery Target MAP of 65 mmHg or above during surgery Target MAP of 65 mmHg or above during the mechanically ventilated phase of ICU admission Exclusion Criteria: Known cardiac shunts (significant) Severe cardiac arrhythmias (including but not limited to persistent atrial fibrillation prior to surgery) Expected to receive an hemodynamic assist device (e.g. intra-aortic balloon pump) during surgery Dialysis dependent kidney failure prior to surgery Planned to receive Perioperative Goal Directed Therapy (PGDT) other than standard intraoperative care Previous cardiac surgery in medical history
Sites / Locations
- Amsterdam University Medical Centers
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control group
Additional HPI guided treatment
Objective to maintain a mean arterial blood pressure (MAP) above or equal to 65 mm Hg, as is standard care in out institution. This is done using standard hemodynamic monitoring, which in our center consists of continuous arterial blood pressure monitoring and the pulse pressure variation parameter. The clinician will administer either fluids, inotropes, vasopressors, or a combination, or apply positional changes to maintain the set MAP threshold.
Objective to maintain a mean arterial blood pressure (MAP) above or equal to 65 mm Hg, as is standard care in out institution. This is done using standard hemodynamic monitoring (as described for the control group) but is assisted by the Hypotension Prediction Index (HPI). This parameter is made available to the clinicians with the HemoSphere Advanced Monitoring Platform (HemoSphere) and is used to initiate treatment when the HPI values is ≥ 75. It also provides additional advanced hemodynamic variables (e.g. cardiac output, systemic vascular resistance). The treating clinicians are trained to use these variables and are provided with a diagnostic flowchart to determine the cause (preload, contractility and afterload) of the upcoming hypotensive (MAP < 65 mmHg) event. Timing of treatment and choice of treatment is then left to the discretion of the attending clinician.